EFPIA - NEWSLETTER

EFPIA Newsletter 09 December 2021

Alzheimer’s disease in the EU during and after pandemic

Discover each piece of the Euractiv Special Report on Alzheimer's:

WHO official: COVID-19 seriously worsened dementia’s state-of-play in Europe
with Dr Natasha Azzopardi Muscat, WHO Europe

Dementia: everyone has heard the word, but no one understands
with Chris Roberts, European Working Group of People with Dementia

Increasingly popular’ patient engagement in Alzheimer research is bearing fruit
with Alzheimer Europe

News

07 December 2021 EFPIA response to EPSCO discussion on Strengthening the European Health Union

EFPIA thanks the Slovenian Presidency for its commitment to advancing the EU healthcare debate, and looks forward to...

Blogs

08 December 2021 Aligning the European Pharmaceutical Industry on a quality approach for industry funded and...

Discover the new EFPIA guideline for its member companies.

Events

24 JAN 2022

Supporting Pharma Innovation in Europe Virtual event

Presented by the FT, in partnership with EFPIA.

Learn more →

08 FEB 2022

EURORDIS Black Pearl Awards (1) Virtual event

The formation of a natural black pearl is extremely rare - just like these pearls, the recipients of the EURORDIS Black...

Learn more →

A once-in-a-generation opportunity to optimise regulatory timelines to improve time to patient access

Only 58% of FDA-licensed therapies reach Europe in a comparable timeline. But for patients, every day counts. This report looks into the 67-day process from the final opinion of the Committee for Medicinal Products for Human Use (CHMP) to the final decision of the European Commission and recommends three solutions to improve patient access.

What we are reading

Keeping vaccines safe and effective 30 November 2021 (Vaccines Europe)

New pandemic wave strikes hardest at people with pre-existing conditions 29 November 2021 (Politico)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶